Femtosecond Laser-Assisted Cataract Surgery



Femtosecond Laser-Assisted Cataract Surgery


John P. Berdahl

Justin A. Schweitzer

Adam R. Bleeker



Since its inception in the early 1980s, the neodymium-doped yttrium aluminum garnet (Nd:YAG) laser has played a pivotal role in clinical eye care. Its revolutionary nanosecond (10-9) pulse rate allowed surgeon’s to treat ocular pathology noninvasively with safe and predictable results. However, the Nd:YAG laser lacked precision, preventing its use in corneal and refractive procedures.

In 1990, Dr. Juhasz and his colleagues at the University of Michigan College of Engineering Center for Ultra-fast Optical Sciences developed a means of shortening the pulse duration of the Nd:YAG laser from the nanosecond (10-9) to femtosecond (10-15) range.1 This decreased energy output and increased peak intensity, leading to micron precision and less surrounding tissue injury.2 In 2008, Nagy et al. described the use of the femtosecond laser during cataract surgery.3 Initial outcomes were promising as all anterior capsulotomies were appropriately sized/centered, and laser-assisted lens fragmentation resulted in less overall phacoemulsification time.3 By 2010, the procedure known as femtosecond laser-assisted cataract surgery (FLACS) had received approval from the United States Food and Drug Administration (FDA).4

While conventional cataract surgery is safe and effective, there remains room for improvement. The femtosecond laser replaces several of the manual steps of cataract surgery, with the goal of improving safety and reproducibility. However, its implementation into primary ophthalmologic care has been slow due to the ongoing debate regarding its advantages over traditional phacoemulsification techniques. Nonetheless, it remains a viable option for ophthalmology practices seeking to offer premium refractive cataract surgery.




CONTRAINDICATIONS


The only relative contraindication to FLACS is a small, non-dilating pupil.7 Pupil dilation is measured preoperatively and should be greater than 6.0 mm. While laser-assisted anterior capsulotomy is possible with a pupil diameter less than 6.0 mm, there is increased risk of injury to the iris (Figure 16.2). Furthermore, if an already small pupil experiences intraoperative miosis following laser pretreatment, subsequent phacoemulsification and lens extraction can be challenging. The size of anterior capsulotomy can be adjusted to accommodate for a small, non-dilating pupil. However, smaller anterior capsulotomies (i.e., less than 4.0 mm in diameter) are at increased risk of capsular phimosis.


INFORMED CONSENT CONSIDERATIONS


The introduction of several new technologies in the cataract surgery space has led to an increased importance of the informed consent process. In order to reduce medicolegal risk associated with cataract surgery, it is important to manage patient
expectations and have documents that support it. The informed consent is intended to promote patient safety and reduce liability exposure when cataract surgery is performed. The decision to proceed with cataract surgery is acceptable once the informed consent process has been shown to be well documented in the patients’ medical record, and the risk/benefits of the procedure are documented on the informed consent.








PREOPERATIVE EVALUATION


A standard cataract evaluation is required prior to FLACS. This includes a thorough review of the patient’s past medical and surgical history. Notably, patients with dry eye may experience worsening of symptoms after FLACS.13 Thus, treating the ocular surface before the procedure is important. This can be achieved in a variety of ways, including artificial tears, topical pharmaceutical agents, punctal plugs, meibomian gland treatments, and nutraceuticals. An algorithm for the treatment of dry eye prior to cataract surgery has been described elsewhere.14 Current medications should also be reviewed as blood thinners may compound the intraoperative bleeding risk. However, discontinuation of these medications is not required.

Visual acuities, manifest refraction, and glare testing are useful in determining the visual significance of the cataract. Undilated slit lamp examination of the anterior segment provides an overall health assessment. Dilated fundus examination establishes baseline vitreoretinal disease and helps to assess pupillary dilation. Surgical planning is completed following ocular biometry, optical coherence tomography, and corneal topography, which aid in selection of the IOL and calibration of the femtosecond laser. On the day of surgery, mydriasis is achieved via the instillation of either of a combination of cyclopentolate 1%, phenylephrine 10%, ketorolac 0.5%, and/or tropicamide 1%.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 23, 2022 | Posted by in OPHTHALMOLOGY | Comments Off on Femtosecond Laser-Assisted Cataract Surgery

Full access? Get Clinical Tree

Get Clinical Tree app for offline access